Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein Barr virus (EBV), a pathogen estimated to ...

Most people have the Epstein-Barr (EBV) virus. Sometimes people are unaware of this virus in their body; it settles into immune cells and remains for the duration.

Peer-reviewed study characterizes in vitro and ex vivo activities of novel antibody agonists generated using Abalone ...

Scientists at Fred Hutch Cancer Center have reported an important advance in the effort to stop Epstein Barr virus (EBV), a ...

Researchers in China recently published a study in Science Translational Medicine describing a new antibody cocktail for ...

Age, biological sex, and human genetic factors influence the production of antibodies during the immune response. A team of ...

Constant exposure to diverse diseases is an occupational hazard for all healthcare workers, especially those who work with children. | Constant exposure to diverse diseases is an occupational hazard ...

Creative Biolabs, a global leader in antibody engineering, today announced its optimization of ADCC and Fc-mediated ...

Are seasonal flu antibodies also effective against avian flu? A team from the University of Geneva (UNIGE) has shown that a ...

Antibodies harvested from the blood of paediatricians are up to 25 times better at protecting against the common respiratory ...

Antibodies are immune proteins that our bodies produce to help fight off infection. Where they recognize and bind a pathogen — and how — can give important clues to the microbe’s vulnerabilities. Fred ...